Evidence map›Paper›PMID 41476261›Full record

ArticleScientific reports2025

Analysis of DNA methyltransferase 3 alpha expression during respiratory syncytial virus strain A infection.

André Luiz Becker, Sofia Giacomet Borges, Lucas Gabriel Rodrigues Pinheiro, Deise Nascimento Freitas, Leonardo Duarte, Eduarda Nunes, Gisele Cassão, Juliana Poppe, Rafaela Pires da Silva, Mariane Schäffer Castro and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

André Luiz BeckerLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Sofia Giacomet BorgesLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Lucas Gabriel Rodrigues PinheiroLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Deise Nascimento FreitasLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Leonardo DuarteLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Eduarda NunesLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Gisele CassãoLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Juliana PoppeLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Rafaela Pires da SilvaLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Mariane Schäffer CastroLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Krist Antunes FernandesLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil.
Cristiano Feijó AndradeThoracic and Pulmonary Surgery Service, Santo Antônio Children's Hospital, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil.
Júlio de Oliveira EspinelThoracic and Pulmonary Surgery Service, Santo Antônio Children's Hospital, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, Brazil.
Vinicius de Rezende RodovalhoLaboratory of Immunoinflammation, Institute of Biology, University of Campinas, Campinas, Brazil.
Marco Aurélio Ramirez VinoloLaboratory of Immunoinflammation, Institute of Biology, University of Campinas, Campinas, Brazil.
Renato T SteinInfant Center, Medical School, PUCRS, Porto Alegre, Brazil.
Ana Paula Duarte de SouzaLaboratory of Clinical and Experimental Immunology, Healthy and Life Science School, Pontifical Catholic University of Rio Grande do Sul, PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil. ana.duarte@pucrs.br.ORCID https://orcid.org/0000-0002-6021-5068

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 309400/2021-0Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Financial Code 001Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 21/2551 - 0001991-3
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is a seasonal pathogen known to cause lower respiratory tract infections, including bronchiolitis and pneumonia, and it is associated with an increased risk of developing asthma and recurrent wheezing in pediatric populations. Epigenetic mechanisms, such as DNA methylation and histone modifications, have been implicated in regulating host immune responses during viral infections. In this study, we investigated DNMT3A expression, a de novo DNA methyltransferase, during RSV infection. We queried the Gene Expression Omnibus (GEO) database for RNA-sequencing datasets related to RSV infection. Among the five relevant datasets identified, one demonstrated significantly elevated DNMT3A expression in RSV-infected samples compared to controls. To validate and further examine this finding, we infected MRC-5 cells, a human lung fibroblast cell line, with RSV-A strain (RSV-A2) and accessed DNMT3A expression at different time points using real-time RT-qPCR. We observed an upregulation of DNMT3A expression at 8 h post-infection; this induction was decreased in the presence of rapamycin, an inhibitor of the mTOR pathway. Immunofluorescence analysis confirms DNMT3A presence in RSV-infected cells. In vivo analysis revealed a significant increase in Dnmt3a expression in murine lung tissue five days following RSV infection. In ex-vivo RSV-infected pediatric lung tissue sample the DNMT3A gene expression was not increase compared to uninfected tissue. Our findings suggest that RSV modulates DNMT3A expression through mTOR pathway, but this effect is transient and dependent on the sample and the kinetics of infection. Our data highlights a potential epigenetic mechanism involved in the gene expression regulation of the host during infection.

Indexed as

DNA (Cytosine-5-)-MethyltransferasesRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAnimalsCell LineDNA MethylationDNA Methyltransferase 3AEpigenesis, GeneticHumansLungMiceTOR Serine-Threonine KinasesDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT3A protein, humanDnmt3a protein, mouseTOR Serine-Threonine KinasesDNMT3AEpigeneticsLungmTORRespiratory syncytial virus

Identifiers

PMID41476261
PMCPMC12855837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.